Since it was started in 2013 by the charity Alcohol Change UK, the Dry January challenge has significantly grown in popularity, becoming a very popular new year's resolution. In 2023, 175,000 people officially signed up to ...
Jan 8, 2025
0
8
Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns.
Nov 13, 2024
0
18
A new mouse model mimicking the liver symptoms of myotonic dystrophy type 1—the most prevalent form of adult-onset muscular dystrophy—provides insight into why patients develop fatty liver disease and display hypersensitivity ...
Oct 24, 2024
0
41
Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related diseases, new research has concluded.
Oct 10, 2024
0
19
Our imagination for artificial intelligence is expansive and ambitious. While there are plenty of dystopian tropes, pop culture is full of hopeful examples of what we believe artificial intelligence could bring to us, ranging ...
Oct 3, 2024
0
40
Participating in a high volume of exercise over a short period of time, such as cycling hundreds of miles in a few days, could reduce body fat levels without weight loss. The first-of-its-kind study is published ahead of ...
Sep 18, 2024
0
88
Scientists from the Medical Faculty Mannheim, Heidelberg University have developed a model system that can be used to test the efficacy of drugs for fatty liver disease. It is a three-dimensional (3D) in vitro cell culture ...
Sep 9, 2024
0
26
An international research group led by the Centenary Institute has developed a new genetic risk prediction tool to identify heavy drinkers most at risk of developing alcohol-associated cirrhosis, a severe form of liver disease.
Aug 28, 2024
0
41
An international study has discovered that people living with the neurodegenerative condition spinal muscular atrophy (SMA) are at higher risk of developing fatty liver disease, suggesting that SMA patients may face additional ...
Jul 17, 2024
0
25
The University of Barcelona has led a study that suggests using the drug known as pemafibrate to treat liver disease associated with metabolic disorders, the most common liver pathology in the world, which affects 1 in 4 ...
Jul 10, 2024
0
48
